CytoImmune Appoints Distinguished Cell Therapy and Chemistry, Manufacturing and Controls Expert as Puerto Rico-Based Chief Operating Officer
Published on: Monday 13 December 2021
TOA BAJA, Puerto Rico, Dec. 14, 2021 (GLOBE NEWSWIRE) -- CytoImmune Therapeutics, a clinical-stage cell immunotherapy company developing novel natural killer (NK) cell therapies to fight cancer, ...
News source: https://finance.yahoo.com/news/cytoimmune-appoints-distinguished-cell-therapy-130000788.html